To set up a press or media interview with this expert contact:

Charles Margulis

Cell: 510-560-3657


Christy McCain, MPH, has more than 20 years of domestic and international health experience, including survey development, training, fieldwork coordination, health education and writing. McCain's expertise lies in maternal and child health and reproductive health issues.

McCain's current research focuses on pregnancy-related mortality among women in California. In collaboration with the Maternal Child and Adolescent Health branch of the California Department of Public Health and the California Maternal Quality Care Collaborative at Stanford, McCain has worked on the Pregnancy-Associated Mortality review since its inception in 2004. She oversees data collection (medical record review), case summary preparation and data analysis for the project. Expertise lies in obstetric deaths, as well as maternal deaths due to suicide and homicide.

McCain's other research includes small evaluation projects (sexual violence prevention, public transportation, earned income tax credit/poverty reduction, global youth leadership in sexual and reproductive health, and a multi-year evaluation of the statewide family planning program.

As a returned Peace Corps volunteer, McCain brings to her research a unique perspective in cross-cultural awareness, humility, a sense of humor and a quest for social justice.

See How Christy McCain, MPH Contributed to Our Impact

Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.


Find Employment

Begin your career at the Public Health Institute.

See Jobs


Breakthrough Infection Study of Over 600,000 Veterans Shows Declining COVID-19 Vaccine Protection

A new pre-print study of over 600,000 veterans by researchers from PHI and the Veterans Affairs Medical Center finds that overall COVID-19 vaccine protection declined significantly between February and August 2021. Declines were greatest for the Johnson & Johnson vaccine (from 88% in March to 3% in August), followed by PfizerBioNTech (91% to 50%) and Moderna (92% to 64%).


Continue to